发明名称 New double-stranded interfering RNA, useful for inhibiting hepatitis C virus, has one strand linked to a lipophilic group to improve activity and eliminate the need for transfection auxiliaries
摘要 Double-stranded RNA (I) having a strand (S1) that is complementary, at least in parts, to a target gene (TG) and, the new feature, linked to at least one lipophilic group (A) is new. An Independent claim is also included for a method for producing (I) by solid-phase synthesis, in the 3' to 5' direction, of S1 and/or S2, that uses in the last synthesis cycle a lipophilic molecule that contains a phosphoramidite group.
申请公布号 DE10302421(A1) 申请公布日期 2004.07.29
申请号 DE20031002421 申请日期 2003.01.21
申请人 RIBOPHARMA AG 发明人 HADWIGER, PHILIPP;JOHN, MATTHIAS;LORENZ, CHRISTINA;VORNLOCHER, HANS-PETER;KREUTZER, ROLAND;LIMMER, STEFAN
分类号 A61K38/00;A61P31/14;C12N15/11;C12N15/113;(IPC1-7):A61K31/713;A61K48/00;A61K31/708;C07H21/02 主分类号 A61K38/00
代理机构 代理人
主权项
地址